These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Prediction of metastasis to mesorectal, internal iliac and obturator lymph nodes according to size criteria in patients with locally advanced lower rectal cancer. Hatano S; Ishida H; Ishiguro T; Kumamoto K; Ishibashi K; Mochiki E; Tamaru J Jpn J Clin Oncol; 2015 Jan; 45(1):35-42. PubMed ID: 25324477 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic performance of multidetector row computed tomography for assessment of lymph node metastasis in patients with distal rectal cancer. Kobayashi H; Kikuchi A; Okazaki S; Ishiguro M; Ishikawa T; Iida S; Uetake H; Sugihara K Ann Surg Oncol; 2015 Jan; 22(1):203-8. PubMed ID: 25124470 [TBL] [Abstract][Full Text] [Related]
7. Predictors of Lateral Pelvic Lymph Node Metastasis in Advanced Low Rectal Cancer Treated With Neoadjuvant Chemotherapy. Ishizaki T; Katsumata K; Enomoto M; Mazaki J; Udo R; Tago T; Kasahara K; Kuwabara H; Nagakawa Y; Tsuchida A Anticancer Res; 2022 Apr; 42(4):2113-2121. PubMed ID: 35347035 [TBL] [Abstract][Full Text] [Related]
8. MRI diagnosis of mesorectal lymph node metastasis in patients with rectal carcinoma. what is the optimal criterion? Matsuoka H; Nakamura A; Sugiyama M; Hachiya J; Atomi Y; Masaki T Anticancer Res; 2004; 24(6):4097-101. PubMed ID: 15736458 [TBL] [Abstract][Full Text] [Related]
9. Correlations between the sizes of lateral pelvic lymph nodes and metastases in rectal cancer patients treated with preoperative chemoradiotherapy. Ishihara S; Kawai K; Tanaka T; Hata K; Nozawa H ANZ J Surg; 2018 Dec; 88(12):1306-1310. PubMed ID: 29974631 [TBL] [Abstract][Full Text] [Related]
10. The important risk factor for lateral pelvic lymph node metastasis of lower rectal cancer is node-positive status on magnetic resonance imaging: study of the Lymph Node Committee of Japanese Society for Cancer of the Colon and Rectum. Ogawa S; Hida J; Ike H; Kinugasa T; Ota M; Shinto E; Itabashi M; Okamoto T; Sugihara K Int J Colorectal Dis; 2016 Oct; 31(10):1719-28. PubMed ID: 27576475 [TBL] [Abstract][Full Text] [Related]
11. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial. Fujita S; Akasu T; Mizusawa J; Saito N; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Shiozawa M; Yamaguchi T; Moriya Y; Lancet Oncol; 2012 Jun; 13(6):616-21. PubMed ID: 22591948 [TBL] [Abstract][Full Text] [Related]
12. Laparoscopic lateral pelvic lymph node dissection is achievable and offers advantages as a minimally invasive surgery over the open approach. Nagayoshi K; Ueki T; Manabe T; Moriyama T; Yanai K; Oda Y; Tanaka M Surg Endosc; 2016 May; 30(5):1938-47. PubMed ID: 26275538 [TBL] [Abstract][Full Text] [Related]
13. Significance of Lateral Pelvic Lymph Node Size in Predicting Metastasis and Prognosis in Rectal Cancer. Lee D; Matsuda T; Yamashita K; Hasegawa H; Yamamoto M; Kanaji S; Oshikiri T; Nakamura T; Suzuki S; Fukumoto T; Kakeji Y Anticancer Res; 2019 Feb; 39(2):993-998. PubMed ID: 30711986 [TBL] [Abstract][Full Text] [Related]
14. Predictive factors of pathological lateral pelvic lymph node metastasis in patients without clinical lateral pelvic lymph node metastasis (clinical stage II/III): The analysis of data from the clinical trial (JCOG0212). Komori K; Fujita S; Mizusawa J; Kanemitsu Y; Ito M; Shiomi A; Ohue M; Ota M; Akazai Y; Shiozawa M; Yamaguchi T; Bandou H; Katsumata K; Kinugasa Y; Takii Y; Akasu T; Moriya Y; Eur J Surg Oncol; 2019 Mar; 45(3):336-340. PubMed ID: 30477950 [TBL] [Abstract][Full Text] [Related]
15. Results of a Japanese nationwide multi-institutional study on lateral pelvic lymph node metastasis in low rectal cancer: is it regional or distant disease? Akiyoshi T; Watanabe T; Miyata S; Kotake K; Muto T; Sugihara K; Ann Surg; 2012 Jun; 255(6):1129-34. PubMed ID: 22549752 [TBL] [Abstract][Full Text] [Related]
16. [Diagnostic accuracy of 3.0T high-resolution MRI for assessment mesorectal lymph node metastases in patients with rectal cancer]. Chen Y; Yang X; Lu B; Xiao X; Zhuang X; Yu S Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Jul; 21(7):786-792. PubMed ID: 30051447 [TBL] [Abstract][Full Text] [Related]
17. Oncological Outcomes of Lateral Pelvic Lymph Node Metastasis in Rectal Cancer Treated With Preoperative Chemoradiotherapy. Ishihara S; Kawai K; Tanaka T; Kiyomatsu T; Hata K; Nozawa H; Morikawa T; Watanabe T Dis Colon Rectum; 2017 May; 60(5):469-476. PubMed ID: 28383446 [TBL] [Abstract][Full Text] [Related]
18. [Lateral pelvic lymph node metastasis is an important prognostic factor for low rectal cancer]. Pan YS; Wan YL; Liu YC; Wang X; Wu T Zhonghua Wai Ke Za Zhi; 2009 Jul; 47(13):984-7. PubMed ID: 19957807 [TBL] [Abstract][Full Text] [Related]
19. Indications for Lateral Pelvic Lymph Node Dissection Based on Magnetic Resonance Imaging Before and After Preoperative Chemoradiotherapy in Patients with Advanced Low-Rectal Cancer. Akiyoshi T; Matsueda K; Hiratsuka M; Unno T; Nagata J; Nagasaki T; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Ueno M Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S614-20. PubMed ID: 25896145 [TBL] [Abstract][Full Text] [Related]
20. Discrimination between Metastatic and Nonmetastatic Mesorectal Lymph Nodes in Rectal Cancer Using Intravoxel Incoherent Motion Diffusion-weighted Magnetic Resonance Imaging. Yu XP; Wen L; Hou J; Bi F; Hu P; Wang H; Wang W Acad Radiol; 2016 Apr; 23(4):479-85. PubMed ID: 26853971 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]